Listeria monocytogenes infectious periaortitis: a case report from the infectious disease standpoint.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
16 Apr 2019
Historique:
received: 22 04 2018
accepted: 04 04 2019
entrez: 18 4 2019
pubmed: 18 4 2019
medline: 6 7 2019
Statut: epublish

Résumé

Endograft infection is a rare but extremely dangerous complication of aortic repair (25-100% of mortality). We describe here the first case of Listeria monocytogenes abdominal periaortitis associated with a vascular graft. We also discuss the differential diagnosis of periaortitis and provide a literature review of L. monocytogenes infectious aortitis. Nine months after endovascular treatment of an abdominal aortic aneurysm (abdominal stent graft), a 76-year-old man was admitted for severe abdominal pain radiating to the back. Laboratory tests were normal apart from elevated C-reactive protein (CRP). Injected abdominal computed tomography (CT) showed infiltration of the fat tissues around the aortic endoprosthesis and aneurysmal sac expansion; positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) showed a hypermetabolic mass in contact with the endoprosthesis. Blood cultures were negative. At surgical revision, an infra-renal peri-aortic abscess was evident; post-operative antibiotic therapy with ciprofloxacin and doxycycline was started. Cultures of intraoperative samples were positive for L. monocytogenes. Results were further confirmed by a broad-range polymerase chain reaction (PCR) and next-generation sequencing. Antibiotic treatment was switched to intravenous amoxicillin for 6 weeks. Evolution was uneventful with decrease of inflammatory parameters and regression of the abscess. An etiologic bacterial diagnosis before starting antibiotic therapy is paramount; nevertheless, culture-independent methods may provide a microbiological diagnosis in those cases where antimicrobials are empirically used and when cultures remain negative.

Sections du résumé

BACKGROUND BACKGROUND
Endograft infection is a rare but extremely dangerous complication of aortic repair (25-100% of mortality). We describe here the first case of Listeria monocytogenes abdominal periaortitis associated with a vascular graft. We also discuss the differential diagnosis of periaortitis and provide a literature review of L. monocytogenes infectious aortitis.
CASE PRESENTATION METHODS
Nine months after endovascular treatment of an abdominal aortic aneurysm (abdominal stent graft), a 76-year-old man was admitted for severe abdominal pain radiating to the back. Laboratory tests were normal apart from elevated C-reactive protein (CRP). Injected abdominal computed tomography (CT) showed infiltration of the fat tissues around the aortic endoprosthesis and aneurysmal sac expansion; positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) showed a hypermetabolic mass in contact with the endoprosthesis. Blood cultures were negative. At surgical revision, an infra-renal peri-aortic abscess was evident; post-operative antibiotic therapy with ciprofloxacin and doxycycline was started. Cultures of intraoperative samples were positive for L. monocytogenes. Results were further confirmed by a broad-range polymerase chain reaction (PCR) and next-generation sequencing. Antibiotic treatment was switched to intravenous amoxicillin for 6 weeks. Evolution was uneventful with decrease of inflammatory parameters and regression of the abscess.
CONCLUSION CONCLUSIONS
An etiologic bacterial diagnosis before starting antibiotic therapy is paramount; nevertheless, culture-independent methods may provide a microbiological diagnosis in those cases where antimicrobials are empirically used and when cultures remain negative.

Identifiants

pubmed: 30991963
doi: 10.1186/s12879-019-3953-z
pii: 10.1186/s12879-019-3953-z
pmc: PMC6469050
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Ciprofloxacin 5E8K9I0O4U
Doxycycline N12000U13O

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

326

Références

J Vasc Surg. 1999 Mar;29(3):554-6
pubmed: 10069921
Diagn Microbiol Infect Dis. 2004 Jan;48(1):63-7
pubmed: 14761724
Hum Pathol. 2004 Sep;35(9):1112-20
pubmed: 15343514
Ann Vasc Surg. 2004 Sep;18(5):521-6
pubmed: 15534730
Lancet. 2006 Jan 21;367(9506):241-51
pubmed: 16427494
Nucleic Acids Res. 2007 Jan;35(Database issue):D61-5
pubmed: 17130148
J Vasc Surg. 2008 Mar;47(3):635-7
pubmed: 18295117
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Br Med J. 1885 Mar 21;1(1264):577-9
pubmed: 20751204
Eur J Vasc Endovasc Surg. 2010 Nov;40(5):582-8
pubmed: 20843713
Bioinformatics. 2010 Dec 15;26(24):3125-6
pubmed: 20956244
J Vasc Surg. 2011 Aug;54(2):327-33
pubmed: 21397443
Case Rep Med. 2011;2011:482815
pubmed: 21765844
BMC Bioinformatics. 2011 Sep 30;12:385
pubmed: 21961884
Int J Surg Case Rep. 2013;4(7):626-8
pubmed: 23711639
Methods. 2013 Sep 1;63(1):41-9
pubmed: 23816787
Heart Lung Circ. 2014 Jan;23(1):24-31
pubmed: 24103706
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Front Cell Infect Microbiol. 2014 May 23;4:65
pubmed: 24904840
Rev Med Interne. 2015 Jan;36(1):15-21
pubmed: 25455951
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
Aorta (Stamford). 2014 Jun 01;2(3):93-9
pubmed: 26798723
Open Forum Infect Dis. 2015 Dec 17;3(1):ofv203
pubmed: 26835477
Cardiovasc Pathol. 2016 Sep-Oct;25(5):432-41
pubmed: 27526100
Gefasschirurgie. 2016;21(Suppl 2):80-86
pubmed: 27546992
Circulation. 2016 Nov 15;134(20):e412-e460
pubmed: 27737955
Ann Vasc Surg. 2017 Jul;42:307.e1-307.e6
pubmed: 28323232
Int J Mol Sci. 2017 Sep 20;18(9):null
pubmed: 28930150
Front Microbiol. 2018 Jul 17;9:1566
pubmed: 30065706
Am J Clin Pathol. 1966 Apr;45(4):493-6
pubmed: 5325707
Histopathology. 1994 Jan;24(1):23-32
pubmed: 7511559

Auteurs

Aurélie Foulex (A)

Service of Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.

Matteo Coen (M)

Service of Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland. matteo.coen@hcuge.ch.
Department of Pathology and Immunology, University of Geneva, Faculty of Medicine, Geneva, Switzerland. matteo.coen@hcuge.ch.

Abdessalam Cherkaoui (A)

Bacteriology Laboratory, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, rue Gabrielle Perret-Gentil 4, 1211, Geneva 14, Switzerland.

Vladimir Lazarevic (V)

Genomic Research Laboratory, Department of Medical Specialties, Geneva University Hospitals and University of Geneva, CMU-C09.2141, rue Michel Servet 1, 1211, Geneva 4, Switzerland.

Nadia Gaïa (N)

Genomic Research Laboratory, Department of Medical Specialties, Geneva University Hospitals and University of Geneva, CMU-C09.2141, rue Michel Servet 1, 1211, Geneva 4, Switzerland.
Genomic Research Laboratory, CMU-C09.2138, rue Michel Servet 1, 1211, Geneva 4, Switzerland.

Stefano Leo (S)

Genomic Research Laboratory, Department of Medical Specialties, Geneva University Hospitals and University of Geneva, CMU-C09.2141, rue Michel Servet 1, 1211, Geneva 4, Switzerland.

Myriam Girard (M)

Genomic Research Laboratory, Department of Medical Specialties, Geneva University Hospitals and University of Geneva, CMU-C09.2141, rue Michel Servet 1, 1211, Geneva 4, Switzerland.

Damiano Mugnai (D)

Service of Cardiac and Vascular Surgery, Department of Surgery, Geneva University Hospitals, rue Gabrielle Perret-Gentil 4, 1211, Geneva 14, Switzerland.

Jacques Schrenzel (J)

Bacteriology Laboratory, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, rue Gabrielle Perret-Gentil 4, 1211, Geneva 14, Switzerland.
Genomic Research Laboratory, Department of Medical Specialties, Geneva University Hospitals and University of Geneva, CMU-C09.2141, rue Michel Servet 1, 1211, Geneva 4, Switzerland.
Service of Infectious Diseases, Department of Medical Specialties, Geneva University Hospitals, Geneva, Switzerland.
Bacteriology Laboratory and Service of Infectious Diseases, Department of Medical Specialties, Geneva University Hospitals, rue Gabrielle Perret-Gentil 4, 1211, Geneva 14, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH